Influence of treatment with immunosuppressive drugs in mice chronically infected with Trypanosoma cruzi

Latent Trypanosoma cruzi infection may be reactivated in immunosuppressed individuals, with unusual clinical patterns, such as meningoencephalitis, pseudo neoplastic lesions in the central nervous system, and myocarditis with numerous parasites in the heart muscle. To investigate this problem 68 Swiss mice chronically infected with different strains of T. cruzi were treated with different combinations of immunosuppressive drugs (azathioprine, cyclosporine and betamethasone), in such a way as to imitate the situation during post transplantation treatment. Mortality varied from 6 to 25% in treated mice. There were no deaths in untreated controls. Normal mice have been submitted to the same schedules of immunosuppression as controls of treatment and no deaths were registered during treatment. Chronically infected mice showed significant elevation of total number of leukocytes and lymphocytes in comparison with intact controls; a significant decrease in blood leukocytes and lymphocytes occurred post‐treatment in two of the treated experimental groups. Exacerbation of myocarditis and myositis and a high incidence of brain lesions, with focal necrosis, granulomatous lesions and glial proliferation even in the absence of parasites were present in immunosuppressed mice but not in infected controls. Although differing in some aspects from Chagas' disease in immunosuppressed humans, the murine model did show some features that resembled it, especially the peculiar pattern of central nervous system involvement.

[1]  S. G. Andrade,et al.  Investigation on the possibility of spontaneous cure of mice infected with different strains of Trypanosoma cruzi. , 1994, Revista do Instituto de Medicina Tropical de Sao Paulo.

[2]  K. Metze,et al.  Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. , 1994, The American journal of tropical medicine and hygiene.

[3]  K. Metze,et al.  AIDS and Chagas' disease , 1993, Neurology.

[4]  S. A. Nishioka,et al.  Acute fatal Trypanosoma cruzi meningoencephalitis in a human immunodeficiency virus-positive hemophiliac patient. , 1991, The American journal of tropical medicine and hygiene.

[5]  L. Libow,et al.  Post-cardiac transplant reactivation of Chagas' disease diagnosed by skin biopsy. , 1991, Cutis.

[6]  F. Pileggi,et al.  Heart transplantation in patients with Chagas' disease cardiomyopathy. , 1987, The Journal of heart transplantation.

[7]  S. G. Andrade,et al.  Enhancement of chronic Trypanosoma cruzi myocarditis in dogs treated with low doses of cyclophosphamide. , 1987, The American journal of pathology.

[8]  A. A. Moreira,et al.  Observacao experimental e preliminar sobre a eventual influencia da ciclosporina na infeccao cronica de camundongos pelo trypanosoma cruzi , 1986 .

[9]  Vanize Macêdo,et al.  Tratamento combinado da Doença de Chagas com Bayer 2502 e corticóide (estudo experimental e clínico) , 1973 .

[10]  A. C. de Queiroz Tumor-like lesion of the brain caused by Trypanosoma cruzi. , 1973, The American journal of tropical medicine and hygiene.

[11]  Z. Brener,et al.  The effects of some immunosuppressive agents in experimental chronic Chagas's disease. , 1971, Transactions of the Royal Society of Tropical Medicine and Hygiene.